Supriya Lifescience Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 147.75 | 187.08 | 187.75 |
| Operating Expense | 93.37 | 116.53 | 119.70 |
| Net Profit | 34.79 | 50.38 | 46.78 |
| Net Profit Margin | 23.55 | 26.93 | 24.92 |
| Earning Per Share | 4.32 | 6.29 | 5.82 |
| EBIDTA | 52.29 | 69.65 | 66.02 |
| Effective Tax Rate | 19.38 | 18.10 | 20.24 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 147.75 |
| Operating Expense | 93.37 |
| Net Profit | 34.79 |
| Net Profit Margin | 23.55 |
| Earning Per Share | 4.32 |
| EBIDTA | 52.29 |
| Effective Tax Rate | 19.38 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 696.49 | 570.34 | 460.94 |
| Operating Expenses Annual | 435.69 | 397.36 | 332.04 |
| Operating Profit Annual | 270.61 | 183.61 | 138.39 |
| Interest Annual | 1.69 | 2.11 | 3.08 |
| Depreciation | 20.44 | 15.81 | 11.82 |
| Net Profit Annual | 187.96 | 119.11 | 89.86 |
| Tax Annual | 60.52 | 46.58 | 33.63 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 696.49 |
| Operating Expenses Annual | 435.69 |
| Operating Profit Annual | 270.61 |
| Interest Annual | 1.69 |
| Depreciation | 20.44 |
| Net Profit Annual | 187.96 |
| Tax Annual | 60.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 74.96 | 157.58 | 227.91 |
| Cash Flow from Operations | 164.68 | 113.31 | 63.61 |
| Cash Flow from Investing | -152.24 | -173.57 | -123.65 |
| Cash Flow from Financing | -8.23 | -22.36 | -10.28 |
| Cash Flow at the End | 79.15 | 74.96 | 157.58 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 74.96 |
| Cash Flow from Operations | 164.68 |
| Cash Flow from Investing | -152.24 |
| Cash Flow from Financing | -8.23 |
| Cash Flow at the End | 79.15 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 34.62 | 28.85 | 26.79 |
| PBIT Margin (%) | 32.01 | 26.41 | 24.50 |
| PBT Margin (%) | 14.33 | 21.28 | 16.54 |
| Net PROFIT Margin (%) | 24.04 | 18.41 | 17.40 |
| Return On Networth / Equity (%) | 20.74 | 15.73 | 13.67 |
| Return On Networth /Employed (%) | 27.43 | 22.05 | 18.43 |
| Return On Assets (%) | 20.67 | 15.47 | 13.05 |
| Total Debt / Equity (X) | 0.01 | 0.02 | 0.04 |
| Asset Turnover Ratio (%) | 0.86 | 0.84 | 0.75 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 34.62 |
| PBIT Margin (%) | 32.01 |
| PBT Margin (%) | 14.33 |
| Net PROFIT Margin (%) | 24.04 |
| Return On Networth / Equity (%) | 20.74 |
| Return On Networth /Employed (%) | 27.43 |
| Return On Assets (%) | 20.67 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 452.87 | 310.13 | 261.54 |
| Total Current Assets Annual | 437.04 | 398.02 | 464.89 |
| Non Current Assets Annual | 675.28 | 523.43 | 355.39 |
| Total Shareholders Funds Annual | 996.76 | 815.37 | 699.46 |
| Total Assets Annual | 1,112.31 | 921.45 | 820.28 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 452.87 |
| Total Current Assets Annual | 437.04 |
| Non Current Assets Annual | 675.28 |
| Total Shareholders Funds Annual | 996.76 |
| Total Assets Annual | 1,112.31 |
No Data Availabe
